Author's Reply: CML as a Second Cancer after CLL
Molecular basis of CLL
Kinase inhibitors overachieve in CLL
Acalabrutinib — a new option in CLL
Control of phage λ development by stability and synthesis of cll protein: Role of the viral clll and host hflA, himA and himD genes
An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data
B-CLL
CLL: Therapy
Ibrutinib outperforms FCR in CLL
CLL: Biology
